Skip to content
Agentic OS
Menu

Intelligence / Healthtech / De Novo Grants / Firalis SA

Approvalsnovel device granted (FDA De Novo)12 Jun 2025

Firalis SA

12 Jun 2025: Novel device granted (FDA De Novo) · APO-Easy Genotyping kit. Recorded in the openFDA device 510(k) (De Novo decisions).

View the source record

Granted
12 Jun 2025
Device
APO-Easy Genotyping kit
Specialty
Immunology
Product Code
SFC
Country
France
Location
Huningue, France
Submitted
2024-06-21
Reference
DEN240032
What this signal means

A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.

  1. 2 added in the 30 days to 19 Nov 2026.
  2. Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS

Find the decision makers at Firalis SA

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

More in Immunology

De Novo Grants

See all

Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.